SwAIPP 2, the continuation of the SwAIPP project, has been funded by Sweden’s innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, healthcare, and industry. In the latest edition of Oncology Sweden, Johan Hartman, and Emelie Karlsson share the journey and impact of SwAIPP.